News and Announcements
Can Investors Be Qualified Directors? Who Takes The Seat At The Board?
- Published December 14, 2022 4:10AM UTC
- Publisher Osama Hassan
- Categories Capital Raising Tips
Lead investors ask for board seats; qualify them first.
Boards play a crucial role in a startup’s success or failure, and with a few precious seats to give out, you want to assure yourself that you’re not just getting a good investor but also a good and productive board member.
Just because someone invests does not mean that:
(a) they know how to be a good director, and
(b) they can help add value to improve the probability of a startup’s success.
Just like investors owe it to themselves to do due diligence on the company they’re about to invest in, founders should also do due diligence on the investor by talking to companies where they serve or have served in the past.
You want both the best investors and the best directors.
Click here to view the original Linkedin post.
Looking for a platform to raise capital? Click here to discover how Wholesale Investor can help you.
Your capital engagement platform
With a 14-year track record, a network of 32,000+ investors, and a capital raising platform, Wholesale investor is a leading investment platform for start-ups, scale-ups, emerging growth companies, and small caps.
Capital Raising Tips
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer
In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.
Dying for a Cure: Why Astraea is Stress-Testing the Future of Space Medicine
Astraea Technologies is solving a critical “blind spot” in the $1.5T space economy. Co-founders Brooke Mills and Gordon Carroll discuss their $5M seed raise, the HIRO-LAB platform, and their upcoming 2028 mission to the Moon to validate life-saving medicine in extreme environments.
Backed By Leading Investment Groups and Family Offices
